2025-522331-34-00CompletedPhase 1
A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144
Source: EU CTIS (euclinicaltrials.eu) · Last updated 9 Sept 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- First submitted
- 6 Aug 2025
- Start date
- 15 Sept 2025
- Lead sponsor
- Pfizer Inc.
- Diseases
- Metastatic breast cancer
- EU CT number
- 2025-522331-34-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 12
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pfizer Clinical Research Unit Coordinator of this site? Confirm its status | Brussels | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.